Background: Athletes need to recover fully to maximise performance in competitive sport. Athletes who replenish more quickly and more efficiently are able to train harder and more intensely. Elite athletes subjectively report positive results using lower body negative pressure (LBNP) treatment as an alternate method for rapid recovery, restoring and improving their impaired physical state. Objective data on the efficacy are lacking. Objectives: To investigate the effect of intermittent vacuum therapy on accelerating acute recovery following an athlete's normal daily training schedule of strenuous exercise. Objective measurements of biological markers of muscular fatigue were used to assess recovery. Methods: Twenty-two male cricket players in a randomised cross-over study were divided into a treatment and control group respectively. Following a one-hour high-intensity gym session, the treatment group received three 30-minute LBNP exposure sessions over three consecutive days (0, 24 and 48 hours). Blood lactate and creatine kinase biomarkers were collected to measure the recovery process. After 14 days groups were crossed over and the trial repeated. Results: Heart rate and blood pressure decreased noticeably during treatment, reverting to baseline levels after treatment. Lactate concentrations decreased in both groups after exercise termination; significantly more in the treatment (0.57±0.23 mmol/l) than control group (0.78±0.22 mmol/l), p<0.001). Creatine kinase (CK) was similar in both groups. Athletes' subjective assessments of recovery rated moderately high. Conclusion: LBNP therapy applied as treatment during routine schedule may have a systemic effect in lowering serum lactate levels, but not CK levels. Enhanced recovery of athletes is still unconfirmed. Keywords: lower body negative pressure, athlete restoration, athlete performance, athlete rehabilitation, athlete recuperation considered to be a good predictor of endurance exercise performance. The lactate threshold is often used to prescribe training intensities, based on the relationship between blood lactate levels and heart rate. In the same way, active recovery after strenuous exercise will clear the accumulated blood lactate levels faster than passive recovery. More so in an intensity-dependent manner, with maximum blood lactate clearance occurring with active recovery close to the lactate threshold. [12, 13] The severity of muscle damage and injury is frequently monitored by blood serum CK enzyme activity levels. [14] Although debated by researchers, lactate concentration and blood serum CK activity levels are implemented as biomarkers in measuring the recovery process that is crucial for successful endurance capacity and sport performance. [12, 13, 14] Hormonal changes in the body are involved in regulating various physiological functions, and when activated are known to improve mental function and willpower, thus automatically increasing the subjective well-being of an individual. [15] The increased blood circulation in the entire body and brain achieved by the vacuum effect of the LBNP device may hypothetically also increase oxygen circulation and influence hormone levels and their release in the blood to enhance a feeling of perceived recovery experienced by the athletes, with the magnitude of improvement remaining of a perceptive nature.
LBNP therapy is becoming popular through the promise of an innovative to optimise and accelerate sports recovery, increase physical performance and reduce breaks from training, with very little confirmed evidence. The objective of this study was to assess if intermittent negative pressure therapy applied to the lower body of athletes will affect known measures of muscular recovery and result in faster recovery time and recuperation.
Methods

Study design
A randomised cross-over study design with repeated measures was performed to determine the effect negative pressure wave treatment has on the recovery of cricketers. An information letter with a full explanation regarding the nature of the study was given to all participants, and informed written consent forms were collected from each candidate prior to the study. The study protocol was approved by the Ethics Committee of the University of Pretoria, South Africa (Approval number 352/2013).
Participants and selection criteria
Twenty-two healthy male cricket players based at the TUKS Cricket Academy, at the High Performance Centre of the University of Pretoria, South Africa, were invited to participate. Players were randomly assigned to one of two groups and evaluated. After the second week the participants were crossed over and the study repeated over the following two weeks. Participant exclusion criteria included cardiovascular diseases, hypotony with proneness to collapse, diabetes, recent phlebotrombosis (<eight weeks), the risk of thromboembolism and smoking. Participants were instructed to refrain from drinking alcohol, and consuming caffeine products 24 hours prior to each study session.
Study procedure
All participants documented their personal information and history before the start of the study. The age, body mass, height and body mass index (BMI) of each athlete were recorded at the start of the study. Each player participated in the cross-over design during the four week study period: once in the treatment group (receiving LBNP treatment; ExT) and once in the control group (not receiving LBNP treatment; ExC). The two applications were separated by a washout period of 14 days. Each trial assessment was completed over three consecutive days and followed the same routine physical, physiological and treatment conduct as illustrated in Figure 1 . The cricket players continued to follow their regular weekly physical training programme consisting of seven hours conditioning and 10 hours cricket specific skills, with one competitive match on weekends, throughout the study period.
Protocol
On the first day of the trial ( Figure 1 ) baseline physiological measurements (heart rate (HR); blood pressure (BP); blood oxygen saturation (SpO2)) and blood samples (Lactate (Lac); Creatine Kinase (CK)) were collected from the participating athletes pre-exercise. Participants then completed a one hour high-intensity gym session comprising of weighted exercises and plyometric upper and lower limb training. Directly after the exercise session, physiological measurements and blood sample collection were repeated. Players were randomly assigned to either receive one 30 minute LBNP treatment session (ExT) or remain seated in the treatment room with no exposure (ExC). A questionnaire (based on an ordinal rating scale of one to five) was completed by each player before and after every LBNP treatment session, to quantify their perceived recovery state (Table 1) . Normal training proceeded in the afternoon and the players returned on Day Two and Day Three during which the same athletes once more received either a treatment session or remained unexposed. Physiological measurements and blood samples were collected daily before and during each treatment session, for both the treatment (ExT) and control (ExC) participants. Treatment sessions were labelled as: 0 hours after, 24 hours after and 48 hours after intense training.
LBNP vacuum therapy
The LBNP device for intermittent vacuum therapy comprises of a cylinder-shaped chamber into which the lower body of the athlete is placed. The athlete lies on his back, his legs and lower body up to the iliac crest bone, inside the chamber. The chamber, enfolding the lower body of the athlete, is sealed by means of a diaphragm (iris seal) around the waist. Alternating negative and normal pressure is generated in the chamber by a vacuum pump. The device generates rhythmic interchanging pressure waves of normal pressure (atmospheric pressure) and negative pressure (lower pressure) at alternating pulsations. A vacuum treatment with negative pressure setting of 68 mbar was regulated, with an atmospheric pressure:negative pressur alternating phase duration of 9:6 seconds. The LBNP device used during this study period was voluntarily supplied by Rapid Sports Medical Regeneration, South Africa.
Physiological measurements
Vital health assessments -heart rate (HR), blood pressure (BP) and blood oxygen saturation (SpO2) -were noted throughout the study, for both the ExT and the ExC athletes. SpO2 (oxyhaemoglobin and deoxy-haemoglobin in the red blood cells) was monitored using a Finger Pulse Oximeter Probe (Anapulse ANP150).
Blood lactate concentration
A small blood sample (0.3µl) was collected by means of a lancet prick of the earlobe to determine the blood lactate concentration (mmol/l) of all athletes (both the ExT group and the ExC group). Analysis was performed using Lactate Pro™2 test strips (Batch# B133B03L) and a portable blood lactate analyser (Arkray Pro2 LT-1730). Lactate was sampled at rest on Day One (Lac0), immediately after the one hour exercise session (Lac1) and directly after the first 30 min LBNP treatment session (Lac2).
Serum creatine kinase enzyme activity levels (CK)
CK levels (IU/litre enzyme activity) were assessed from approximately five ml of blood drawn from an antecubital vein by venipuncture. Blood samples were obtained at baseline and at 0 hours, 24 hours and 48 hours respectively after treatment and were analysed (Creatine Phosphokinase Assay; Beckman UniCel ® DxC800 Synchron) to determine possible increases in CK blood serum levels.
Perceived recovery questionnaire
The questionnaire was based on an ordinal rating scale of one to five, to evaluate the perceived amount of recovery with LBNP therapy (of all athletes: ExC and ExT). The questions were designed to explore the subjective perceptions of their intensity of muscle soreness and their level of recovery, comparing pre-treatment and post-treatment on the LBNP device (Table 1) . Athletes belonging to the ExT group were also questioned on their opinion of the effectiveness of LBNP therapy.
Data analysis
The data analysis consisted of descriptive statistics to The results of the perceived recovery questionnaire were combined into pre-treatment recovery scores and posttreatment recovery scores. Non-parametric Mann-Whitney U tests were performed to determine differences between the treatment and control groups for each of the three periods. The results were regarded as significant if p<0.05, one-tailed.
Results
The baseline physical characteristics of the participants at the start of the study are reported in Table 2 . Figure 2 shows the systolic and diastolic BP for both the ExT and the ExC athletes. The negative pressure generated by the LBNP device on BP can clearly be seen in the systolic and diastolic fluctuations during the treatment sessions. Although there were slight changes in the HR and SpO2 measurements before and during each treatment session in the ExT and ExC groups, there were no significant differences in these physiological measurements; these differences are due to sample variation. Figure 3 illustrates the results of the blood lactate concentration (mmol/l) on Day One at baseline (Lac0), after a one hour (Lac1) intense exercise session, and after the first 30 minute (Lac2) LBNP therapy session. The average blood lactate concentration (mmol/l) ratio (after vs. before) of the ExT group decreased after treatment, in comparison to the ExC group who did not receive treatment (0.57±0.23 vs. 0.78±0.22, respectively, F(1;19)=9.420, p=0.006). No other significant differences were obtained.
The CK measurements for both groups are shown in Figure  4 . Although there was an increase in CK enzyme activity following the first day's training, the CK did not decrease significantly after three treatment sessions on the LBNP device (F(1;19)=0.172; p=0.683). Figure 5 shows the perceived recovery grading of both ExC and ExT athletes over a three day period during pre-treatment and post-treatment on the LBNP device (based on the questions in Table 1 ). The three pre-treatment questions were combined to get a pre-treatment recovery score, and the three posttreatment questions were combined to get a post-treatment recovery score. There was a significant difference between the ExC and ExT groups (post-treatment score minus pre-treatment score) at all three time periods (0h p= 0.011; 24h p<0.001; 48h p=0.001). At post-treatment, after each of the 0 hour, 24 hour and 48 hour sessions, the ExT athletes reported a significant increase in their perceived degree of muscle feel, fatigue and recovery compared to the controls. The ExT group during each of the treatment periods indicated higher energy and recovery status than the ExC group.
Discussion
The decrease in the blood lactate concentration ratio of the treatment group compared to the control group (0.57±0.23 vs. 0.78±0.22 mmol/l, respectively, p<0.001), following a single negative pressure treatment session, indicates that the use of the LBNP device succeeded in normalising lactate measurements more quickly, and may imply faster athlete rehabilitation and recovery. Per contra, the severity of muscle injury as indicated by the blood serum CK level of activity was not significantly reduced after three treatment sessions of negative pressure (F(1;19)=0.172; p=0.683).
Negative vacuum pressure treatment did not affect the ongoing sports performance of the athletes, and no side effects were observed during the period the study was executed. All participants also form part of the same cricket academy and therefore their training schedules are fairly similar.
Several physiological systems change when endurance training is induced (i.e. metabolic, cardiovascular, muscular, etc.), with the modification of lactate kinetic parameters a significant mediator to quantify the extent of exercise. [12] The mean blood lactate ratio between the control (ExC) and treatment (ExT) groups, directly after exercise vs. directly However, the daily academy training and competition programme the athletes followed, although fairly similar, may also have influenced the CK serum results. Again, the objective of evaluating negative pressure effect on recovery under acute athlete performance conditions is highlighted in this study.
The stimulation of the circulatory system and the lymphatic vessels by the rhythmic alternating pressure of the LBNP device may conceivably mimic massage therapy. Sports massage is used by athletes with the belief that it will stimulate lymph flow and reduce muscle tightness in order to accelerate recovery and enhance performance. Improvement in muscle tone and a sense of feeling recovered and energised by the increased concentration of endorphins in the brain has also been advocated. Although many claimed benefits and numerous personal perceived experiences promote sports massage as the treatment of choice, research evidence on its appropriate use is scarce [10] with contradictory evidence that manual massage has any significant impact on the physiological and psychological factors associated with recovery following exercise. [9, 10] Recovery may be reliably assessed both at pre-and posttreatment with one-dimensional tools, such as individual evaluated numeric rating scales. Athletes who were treated with the LBNP device during their routine weekly training programme reported an increased subjective impression of treatment compared to that of the control athletes. A perceived improvement in muscle feeling and fatigue was seen, and they experienced increased training motivation and an enhanced feeling of recovery in general. The athletes described the treatments as 'pleasant' and rated their treatment sessions on the LBNP device as highly effective, reflecting the impression that the treatment sessions may help them to recover more quickly. At posttreatment, after each of the 0 hour, 24 hour and 48 hour sessions, the ExT athletes reported a significant increase in their perceived degree of muscle feel, fatigue and recovery compared to the controls. The ExT group, during each of the treatment periods, indicated a higher energy and recovery status than the ExC group. The perceived perceptions of recovery that increased after each vacuum therapy session provides some support for the use of the LBNP device as a recovery strategy to improve the recovery state of the athlete. It has to be noted that the project specifically targeted short-term acute recovery and does not reflect on how the use of the LBNP device will be perceived over the long-term. The performance, motivation and subjective wellbeing of the athlete may well be further enhanced with the continuous use of the device. A limitation to this study is the short period the LBNP treatment was implemented, but the core emphasis was to determine acute athlete rehabilitation and recovery based on known measures of muscular recovery within a short period of time after high-intensity exercise. Beneficial to the device itself will be a further examination of its effectiveness and significance based on performance enhancement, recovery and rehabilitation of athletes, and the advanced development of various treatment programmes.
Conclusion
Based on this study, LBNP therapy implemented as an applied treatment within cricket players' normal routine training and competition schedule, in an effort to assist in the recovery of players over a short period of time, seems to have a systemic effect in lowering serum lactate levels, but not CK levels. The enhanced long-term recovery of athletes using this device to replenish faster and recuperate more efficiently as advocated, are still unconfirmed.
